MRKNYSE— Merck & Company Inc Price & Analysis

Merck & Company Inc

HEALTHCARE — DRUG MANUFACTURERS - GENERAL

$146.76

-$0.39-0.27%

Market Cap: $363.04B; Mega Cap
P/E Ratio: 115.87; Fwd: 14.95
EPS (TTM): $1.27
Div. Yield: 2.29%

Technical Summary

RSI (14)56.73Neutral

SMA (50)$137.13Bullish

SMA (200)$118.92Bullish

MACD2.1026Bearish

Bollinger$141.64 – $154.42Mid

Stochastic41.22Neutral

Company Overview

Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.

Fundamental Snapshot

Revenue: $66.57B
EBITDA: $28.87B
Gross Profit: $50.53B
Operating Margin: -0.2%
Profit Margin: 4.8%
ROE: 7.0%
Book Value: $16.99
Beta: 0.23
52-Wk High: $156.00
52-Wk Low: $75.37
Avg Volume: 29.12M
PEG Ratio: 2.65

Trading Data

Open: $147.08
Previous Close: $147.15
Day Range: $145.74 – $147.84
Volume: 30.47M
Shares Outstanding: 2.47B
Analyst Target: $152.96

Related Assets

Intuitive Surgical Inc

$393.33

+2.55%

VRTX

Vertex Pharmaceuticals Inc

$508.34

-1.55%

REGN

Regeneron Pharmaceuticals Inc

$784.85

-0.58%

Get Deeper Analysis

Ask Theo anything about MRK — earnings, valuation, technicals, or portfolio fit.

Try HeyTheo Free